| 1 | [SID103538185] | Active | IC50 | 3.75 | Inhibition of wild type human Jurkat cells after 18 hrs by MTT assay [AID357402, Type: Literature] | |   View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 103538185 | | CID | 122121 | | Outcome | Active | | IC50 | 3.75 [uM] | | BioAssay | Inhibition of wild type human Jurkat cells after 18 hrs by MTT assay | | AID | 357402 | | BioAssay type | Literature | | Target | | | PubMed | 17400555 | | Data Table |  |
|
| 2 | [SID103538185] | Active | IC50 | 4.12 | Inhibition of human 2-amino-4-(4-heptyloxyphenyl)-2-methylbutanol-resistant human Jurkat SBR3 mutant cells proliferation after 18 hrs by MTT assay [AID357394, Type: Literature] | |   View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 103538185 | | CID | 122121 | | Outcome | Active | | IC50 | 4.12 [uM] | | BioAssay | Inhibition of human 2-amino-4-(4-heptyloxyphenyl)-2-methylbutanol-resistant human Jurkat SBR3 mutant cells proliferation after 18 hrs by MTT assay | | AID | 357394 | | BioAssay type | Literature | | Target | | | PubMed | 17400555 | | Data Table |  |
|
| 3 | [SID103538185] | Active | IC50 | 5.29 | Inhibition of 2-amino-4-(4-heptyloxyphenyl)-2-methylbutanol-resistant human Jurkat SBR2 mutant cells proliferation after 18 hrs by MTT assay [AID357393, Type: Literature] | |   View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 103538185 | | CID | 122121 | | Outcome | Active | | IC50 | 5.29 [uM] | | BioAssay | Inhibition of 2-amino-4-(4-heptyloxyphenyl)-2-methylbutanol-resistant human Jurkat SBR2 mutant cells proliferation after 18 hrs by MTT assay | | AID | 357393 | | BioAssay type | Literature | | Target | | | PubMed | 17400555 | | Data Table |  |
|
| 4 | [SID103538185] | Active | IC50 | 6.57 | Inhibition of 2-amino-4-(4-heptyloxyphenyl)-2-methylbutanol-resistant human Jurkat SBR1 mutant cells proliferation after 18 hrs by MTT assay [AID357392, Type: Literature] | |   View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 103538185 | | CID | 122121 | | Outcome | Active | | IC50 | 6.57 [uM] | | BioAssay | Inhibition of 2-amino-4-(4-heptyloxyphenyl)-2-methylbutanol-resistant human Jurkat SBR1 mutant cells proliferation after 18 hrs by MTT assay | | AID | 357392 | | BioAssay type | Literature | | Target | | | PubMed | 17400555 | | Data Table |  |
|
| 5 | [SID103538185] | Active | | | Cytotoxicity against human Jurkat cells at 10 uM after 30 mins [AID302642, Type: Literature] | |   View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 103538185 | | CID | 122121 | | Outcome | Active | | BioAssay | Cytotoxicity against human Jurkat cells at 10 uM after 30 mins | | AID | 302642 | | BioAssay type | Literature | | Target | | | PubMed | 17920885 | | Data Table |  |
|
| 6 | [SID103538185] | Active | | | Induction of endogenous ROS accumulation in Candida albicans CAI4 after 3 hrs by 2',7'-dichlorofluorescein diacetate staining [AID407131, Type: Literature] | |   View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 103538185 | | CID | 122121 | | Outcome | Active | | BioAssay | Induction of endogenous ROS accumulation in Candida albicans CAI4 after 3 hrs by 2',7'-dichlorofluorescein diacetate staining | | AID | 407131 | | BioAssay type | Literature | | Target | | | PubMed | 18524581 | | Data Table |  |
|
| 7 | [SID103538185] | Unspecified | Ki | 850 | Inhibition of Rhodococcus sp. M777 Endoglycoceramidase 2 containing wild type sequence E351S [AID499032, Type: Literature] | |   View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 103538185 | | CID | 122121 | | Outcome | Unspecified | | Ki | 850 [uM] | | BioAssay | Inhibition of Rhodococcus sp. M777 Endoglycoceramidase 2 containing wild type sequence E351S | | AID | 499032 | | BioAssay type | Literature | | Target | | | PubMed | 19525967 | | Data Table |  |
|
| 8 | [SID103538185] | Unspecified | | | Ratio of Kcat to Km of Activity of Rhodococcus sp. M777 Endoglycoceramidase 2 V101M K200R mutant [AID499029, Type: Literature] | |   View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 103538185 | | CID | 122121 | | Outcome | Unspecified | | BioAssay | Ratio of Kcat to Km of Activity of Rhodococcus sp. M777 Endoglycoceramidase 2 V101M K200R mutant | | AID | 499029 | | BioAssay type | Literature | | Target | | | PubMed | 19525967 | | Data Table |  |
|
| 9 | [SID103538185] | Unspecified | | | Ratio of Kcat to Km of Activity of Rhodococcus sp. M777 Endoglycoceramidase 2 K129N mutant [AID499030, Type: Literature] | |   View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 103538185 | | CID | 122121 | | Outcome | Unspecified | | BioAssay | Ratio of Kcat to Km of Activity of Rhodococcus sp. M777 Endoglycoceramidase 2 K129N mutant | | AID | 499030 | | BioAssay type | Literature | | Target | | | PubMed | 19525967 | | Data Table |  |
|
| 10 | [SID103538185] | Unspecified | | | Ratio of Kcat to Km of Activity of Rhodococcus sp. M777 Endoglycoceramidase 2 N148S mutant [AID499031, Type: Literature] | |   View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 103538185 | | CID | 122121 | | Outcome | Unspecified | | BioAssay | Ratio of Kcat to Km of Activity of Rhodococcus sp. M777 Endoglycoceramidase 2 N148S mutant | | AID | 499031 | | BioAssay type | Literature | | Target | | | PubMed | 19525967 | | Data Table |  |
|
| 11 | [SID103538185] | Unspecified | | | Resistance index, ratio of IC50 for 2-amino-4-(4-heptyloxyphenyl)-2-methylbutanol-resistant human Jurkat SBR1 mutant cells to IC50 for human wild type Jurkat cells [AID357403, Type: Literature] | |   View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 103538185 | | CID | 122121 | | Outcome | Unspecified | | BioAssay | Resistance index, ratio of IC50 for 2-amino-4-(4-heptyloxyphenyl)-2-methylbutanol-resistant human Jurkat SBR1 mutant cells to IC50 for human wild type Jurkat cells | | AID | 357403 | | BioAssay type | Literature | | Target | | | PubMed | 17400555 | | Data Table |  |
|
| 12 | [SID103538185] | Unspecified | | | Resistance index, ratio of IC50 for 2-amino-4-(4-heptyloxyphenyl)-2-methylbutanol-resistant human Jurkat SBR2 mutant cells to IC50 for human wild type Jurkat cells [AID357404, Type: Literature] | |   View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 103538185 | | CID | 122121 | | Outcome | Unspecified | | BioAssay | Resistance index, ratio of IC50 for 2-amino-4-(4-heptyloxyphenyl)-2-methylbutanol-resistant human Jurkat SBR2 mutant cells to IC50 for human wild type Jurkat cells | | AID | 357404 | | BioAssay type | Literature | | Target | | | PubMed | 17400555 | | Data Table |  |
|
| 13 | [SID103538185] | Unspecified | | | Resistance index, ratio of IC50 for 2-amino-4-(4-heptyloxyphenyl)-2-methylbutanol-resistant human Jurkat SBR3 mutant cells to IC50 for human wild type Jurkat cells [AID357405, Type: Literature] | |   View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 103538185 | | CID | 122121 | | Outcome | Unspecified | | BioAssay | Resistance index, ratio of IC50 for 2-amino-4-(4-heptyloxyphenyl)-2-methylbutanol-resistant human Jurkat SBR3 mutant cells to IC50 for human wild type Jurkat cells | | AID | 357405 | | BioAssay type | Literature | | Target | | | PubMed | 17400555 | | Data Table |  |
|
| 14 | [SID103538185] | Unspecified | | | Fungicidal activity against Candida glabrata BG2 [AID407127, Type: Literature] | |   View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 103538185 | | CID | 122121 | | Outcome | Unspecified | | BioAssay | Fungicidal activity against Candida glabrata BG2 | | AID | 407127 | | BioAssay type | Literature | | Target | | | PubMed | 18524581 | | Data Table |  |
|
| 15 | [SID103538185] | Unspecified | | | Fungicidal activity against Candida albicans CAI4 [AID407128, Type: Literature] | |   View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 103538185 | | CID | 122121 | | Outcome | Unspecified | | BioAssay | Fungicidal activity against Candida albicans CAI4 | | AID | 407128 | | BioAssay type | Literature | | Target | | | PubMed | 18524581 | | Data Table |  |
|
| 16 | [SID103538185] | Unspecified | | | Fungicidal activity against Candida albicans CAI4 in presence of 10 mM ascorbic acid [AID407129, Type: Literature] | |   View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 103538185 | | CID | 122121 | | Outcome | Unspecified | | BioAssay | Fungicidal activity against Candida albicans CAI4 in presence of 10 mM ascorbic acid | | AID | 407129 | | BioAssay type | Literature | | Target | | | PubMed | 18524581 | | Data Table |  |
|
| 17 | [SID26756990] | Inactive | Potency | 79.4328 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 26756990 | | CID | 122121 | | Outcome | Inactive | | Potency | 79.4328 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 18 | [SID26756990] | Inactive | Potency | 79.4328 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 26756990 | | CID | 122121 | | Outcome | Inactive | | Potency | 79.4328 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 19 | [SID26756990] | Inactive | Potency | 79.4328 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 26756990 | | CID | 122121 | | Outcome | Inactive | | Potency | 79.4328 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 20 | [SID26756990] | Inactive | Potency | 79.4328 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 26756990 | | CID | 122121 | | Outcome | Inactive | | Potency | 79.4328 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 21 | [SID26756990] | Inactive | Potency | | VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity [AID2546, Type: confirmatory] | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 26756990 | | CID | 122121 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity | | AID | 2546 | | BioAssay type | confirmatory | | Target | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] | | PubMed | | | Data Table |  |
|
| 22 | [SID26756990] | Inactive | Potency | | qHTS for inhibitors of ROR gamma transcriptional activity [AID2551, Type: confirmatory] | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 26756990 | | CID | 122121 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for inhibitors of ROR gamma transcriptional activity | | AID | 2551 | | BioAssay type | confirmatory | | Target | nuclear receptor ROR-gamma [Mus musculus] [gi:188536040] | | PubMed | | | Data Table |  |
|
| 23 | [SID103538185] | Inactive | | | Cytotoxicity against gamma irradiated human Jurkat cells at 10 uM after 30 mins relative to control [AID302643, Type: Literature] | |   View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 103538185 | | CID | 122121 | | Outcome | Inactive | | BioAssay | Cytotoxicity against gamma irradiated human Jurkat cells at 10 uM after 30 mins relative to control | | AID | 302643 | | BioAssay type | Literature | | Target | | | PubMed | 17920885 | | Data Table |  |
|
| 24 | [SID26756990] | Inactive | Potency | | qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1) [AID485290, Type: confirmatory] | Chain A, Crystal Structure Of Human Tyrosyl-Dna Phosphodiesterase (Tdp1) [gi:20150581] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 26756990 | | CID | 122121 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1) | | AID | 485290 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of Human Tyrosyl-Dna Phosphodiesterase (Tdp1) [gi:20150581] | | PubMed | | | Data Table |  |
|
| 25 | [SID26756990] | Inactive | | | Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin [AID2314, Type: screening] | shiga toxin 1 variant A subunit [Escherichia coli O157:H7] [gi:32400299] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 26756990 | | CID | 122121 | | Outcome | Inactive | | BioAssay | Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin | | AID | 2314 | | BioAssay type | screening | | Target | shiga toxin 1 variant A subunit [Escherichia coli O157:H7] [gi:32400299] | | PubMed | | | Data Table |  |
|
| 26 | [SID26756990] | Inactive | | | A qHTS for Small Molecule Inhibitors of Shiga Toxin [AID2315, Type: screening] | shiga toxin 1 variant A subunit [Escherichia coli O157:H7] [gi:32400299] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 26756990 | | CID | 122121 | | Outcome | Inactive | | BioAssay | A qHTS for Small Molecule Inhibitors of Shiga Toxin | | AID | 2315 | | BioAssay type | screening | | Target | shiga toxin 1 variant A subunit [Escherichia coli O157:H7] [gi:32400299] | | PubMed | | | Data Table |  |
|
| 27 | [SID26756990] | Inactive | Potency | | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia [AID2451, Type: confirmatory] | Chain A, Structure Of Giardia Fructose-1,6-Biphosphate Aldolase In Complex With Phosphoglycolohydrox [gi:122920737] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 26756990 | | CID | 122121 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia | | AID | 2451 | | BioAssay type | confirmatory | | Target | Chain A, Structure Of Giardia Fructose-1,6-Biphosphate Aldolase In Complex With Phosphoglycolohydrox [gi:122920737] | | PubMed | | | Data Table |  |
|
| 28 | [SID26756990] | Inactive | Potency | | qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS [AID602332, Type: confirmatory] | heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) [Homo sapiens] [gi:168984549] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 26756990 | | CID | 122121 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS | | AID | 602332 | | BioAssay type | confirmatory | | Target | heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) [Homo sapiens] [gi:168984549] | | PubMed | | | Data Table |  |
|
| 29 | [SID26756990] | Inactive | Potency | | qHTS Assay for Identification of Novel General Anesthetics [AID485281, Type: confirmatory] | Chain A, Horse Spleen Apoferritin [gi:254220970] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 26756990 | | CID | 122121 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Identification of Novel General Anesthetics | | AID | 485281 | | BioAssay type | confirmatory | | Target | Chain A, Horse Spleen Apoferritin [gi:254220970] | | PubMed | | | Data Table |  |
|
| 30 | [SID26756990] | Inactive | Potency | | qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1) [AID2549, Type: confirmatory] | Chain A, Structure Of Human Recq-Like Helicase In Complex With A Dna Substrate [gi:282403581] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 26756990 | | CID | 122121 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1) | | AID | 2549 | | BioAssay type | confirmatory | | Target | Chain A, Structure Of Human Recq-Like Helicase In Complex With A Dna Substrate [gi:282403581] | | PubMed | | | Data Table |  |
|
| 31 | [SID26756990] | Inactive | Potency | | qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM) [AID2528, Type: confirmatory] | Bloom syndrome protein [Homo sapiens] [gi:4557365] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 26756990 | | CID | 122121 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM) | | AID | 2528 | | BioAssay type | confirmatory | | Target | Bloom syndrome protein [Homo sapiens] [gi:4557365] | | PubMed | | | Data Table |  |
|
| 32 | [SID26756990] | Inactive | Potency | | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate [AID2112, Type: confirmatory] | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 26756990 | | CID | 122121 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate | | AID | 2112 | | BioAssay type | confirmatory | | Target | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] | | PubMed | | | Data Table |  |
|
| 33 | [SID26756990] | Inactive | Potency | | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate [AID2112, Type: confirmatory] | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 26756990 | | CID | 122121 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate | | AID | 2112 | | BioAssay type | confirmatory | | Target | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] | | PubMed | | | Data Table |  |
|
| 34 | [SID26756990] | Inactive | Potency | | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate [AID2112, Type: confirmatory] | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 26756990 | | CID | 122121 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate | | AID | 2112 | | BioAssay type | confirmatory | | Target | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] | | PubMed | | | Data Table |  |
|
| 35 | [SID26756990] | Inactive | | | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen [AID2472, Type: screening] | glyceraldehyde-3-phosphate dehydrogenase [Homo sapiens] [gi:7669492] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 26756990 | | CID | 122121 | | Outcome | Inactive | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen | | AID | 2472 | | BioAssay type | screening | | Target | glyceraldehyde-3-phosphate dehydrogenase [Homo sapiens] [gi:7669492] | | PubMed | | | Data Table |  |
|
| 36 | [SID26756990] | Inactive | | | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen [AID2472, Type: screening] | glyceraldehyde-3-phosphate dehydrogenase [Homo sapiens] [gi:7669492] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 26756990 | | CID | 122121 | | Outcome | Inactive | | BioAssay | qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen | | AID | 2472 | | BioAssay type | screening | | Target | glyceraldehyde-3-phosphate dehydrogenase [Homo sapiens] [gi:7669492] | | PubMed | | | Data Table |  |
|
| 37 | [SID26756990] | Inactive | Potency | | qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease [AID2101, Type: confirmatory] | glucocerebrosidase [Homo sapiens] [gi:496369] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 26756990 | | CID | 122121 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease | | AID | 2101 | | BioAssay type | confirmatory | | Target | glucocerebrosidase [Homo sapiens] [gi:496369] | | PubMed | | | Data Table |  |
|
| 38 | [SID26756990] | Inactive | Potency | | qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease [AID2101, Type: confirmatory] | glucocerebrosidase [Homo sapiens] [gi:496369] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 26756990 | | CID | 122121 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease | | AID | 2101 | | BioAssay type | confirmatory | | Target | glucocerebrosidase [Homo sapiens] [gi:496369] | | PubMed | | | Data Table |  |
|
| 39 | [SID26756990] | Inactive | Potency | | qHTS Assay for Inhibitors of GCN5L2 [AID504327, Type: confirmatory] | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 26756990 | | CID | 122121 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of GCN5L2 | | AID | 504327 | | BioAssay type | confirmatory | | Target | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] | | PubMed | | | Data Table |  |
|
| 40 | [SID26756990] | Inactive | Potency | | qHTS Assay for Inhibitors of GCN5L2 [AID504327, Type: confirmatory] | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 26756990 | | CID | 122121 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of GCN5L2 | | AID | 504327 | | BioAssay type | confirmatory | | Target | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] | | PubMed | | | Data Table |  |
|
| 41 | [SID26756990] | Inactive | Potency | | qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate [AID2107, Type: confirmatory] | alpha-galactosidase [Homo sapiens] [gi:757912] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 26756990 | | CID | 122121 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate | | AID | 2107 | | BioAssay type | confirmatory | | Target | alpha-galactosidase [Homo sapiens] [gi:757912] | | PubMed | | | Data Table |  |
|
| 42 | [SID26756990] | Inactive | Potency | | qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate [AID2107, Type: confirmatory] | alpha-galactosidase [Homo sapiens] [gi:757912] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 26756990 | | CID | 122121 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate | | AID | 2107 | | BioAssay type | confirmatory | | Target | alpha-galactosidase [Homo sapiens] [gi:757912] | | PubMed | | | Data Table |  |
|
| 43 | [SID26756990] | Inactive | Potency | | qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide [AID1766, Type: confirmatory] | MEN1 gene product [Homo sapiens] [gi:18860839] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 26756990 | | CID | 122121 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide | | AID | 1766 | | BioAssay type | confirmatory | | Target | MEN1 gene product [Homo sapiens] [gi:18860839] | | PubMed | | | Data Table |  |
|
| 44 | [SID26756990] | Inactive | Potency | | qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide [AID1768, Type: confirmatory] | MEN1 gene product [Homo sapiens] [gi:18860839] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 26756990 | | CID | 122121 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide | | AID | 1768 | | BioAssay type | confirmatory | | Target | MEN1 gene product [Homo sapiens] [gi:18860839] | | PubMed | | | Data Table |  |
|
| 45 | [SID26756990] | Inactive | Potency | | Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 [AID1479, Type: confirmatory] | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 26756990 | | CID | 122121 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 | | AID | 1479 | | BioAssay type | confirmatory | | Target | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] | | PubMed | | | Data Table |  |
|
| 46 | [SID26756990] | Inactive | Potency | | Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 [AID1479, Type: confirmatory] | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 26756990 | | CID | 122121 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 | | AID | 1479 | | BioAssay type | confirmatory | | Target | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] | | PubMed | | | Data Table |  |
|
| 47 | [SID26756990] | Inactive | Potency | | Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 [AID1479, Type: confirmatory] | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 26756990 | | CID | 122121 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 | | AID | 1479 | | BioAssay type | confirmatory | | Target | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] | | PubMed | | | Data Table |  |
|
| 48 | [SID26756990] | Inactive | Potency | | qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 [AID1469, Type: confirmatory] | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 26756990 | | CID | 122121 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 | | AID | 1469 | | BioAssay type | confirmatory | | Target | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] | | PubMed | | | Data Table |  |
|
| 49 | [SID26756990] | Inactive | Potency | | qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 [AID1469, Type: confirmatory] | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 26756990 | | CID | 122121 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 | | AID | 1469 | | BioAssay type | confirmatory | | Target | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] | | PubMed | | | Data Table |  |
|
| 50 | [SID26756990] | Inactive | Potency | | qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 [AID1469, Type: confirmatory] | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 26756990 | | CID | 122121 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2 | | AID | 1469 | | BioAssay type | confirmatory | | Target | thyroid hormone receptor beta [Homo sapiens] [gi:189491771] | | PubMed | | | Data Table |  |
|